-
Most Recent
Search Results
240 results for ptie
Is the “AI Bubble” a Ghost Story? Here’s What the Numbers Say…
In today’s Market 360, let’s look at the numbers and see which companies are proving the AI boom is built on substance – and which…
Earnings Growth Hamper Pain Therapeutics (PTIE) Rating
The current recommendation of Hold for Pain Therapeutics Inc (NASDAQ:PTIE) is derived using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier’s investing approach.…
Pain Therapeutics Jumps 50% on Promising Remoxy Study (PTIE)
Pain Therapeutics (PTIE) stock is soaring Tuesday after its REMOXY study shows the drug could deter prescription painkiller abuse.
Remoxy’s Rejection Drives PTIE Stock 70% Lower
The FDA Advisory Committee’s decision to vote against Remoxy has left PTIE stock in the dumps because the firm has very few other options coming…
3 Stocks to Watch on Monday: Twitter Inc (TWTR), Walt Disney Co (DIS) and Pain Therapeutics, Inc. (PTIE)
Twitter (TWTR) gets a downgrade amid buyout rumors, Disney (DIS) is lowered too and Pain Therapeutics (PTIE) suffers a huge setback.
Biotech Movers: Enzo Biochem Rockets on Patent Ruling
ENZ is awarded $48.6 million in penalties, and more could be coming. Plus: Why Abiomed, Pain Therapeutics, Impax and BioCryst all took big falls.
Pain Therapeutics Stock Skyrockets on Alzheimer’s Grant
Pain Therapeutics (PTIE) stock was soaring Wednesday on news of a grant to study Alzheimer’s disease from the National Institutes of Health.
3 Pharmaceuticals Stocks to Sell Now
The overall ratings of 3 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
6 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
6 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
4 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of four Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…
Hottest Manufacturing Stocks Now – BSPM SRPT GBT AERI
The following stocks were moving the Manufacturing sector today.
5 Pharmaceuticals Stocks to Buy Now
This week, 5 Pharmaceuticals stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Biggest Movers in Manufacturing Stocks Now – DMTX TRIL NTLA FATE
The following stocks were moving the Manufacturing sector today.
Hottest Manufacturing Stocks Now – YECO ADMS ADAP NTLA
The following stocks were moving the Manufacturing sector today.
6 Pharmaceuticals Stocks to Buy Now
The grades of 6 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…
Hottest Manufacturing Stocks Now – AEGR IDRA LJPC ESPR
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Manufacturing Stocks Now – GURE ARDM OCRX KURA
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – NL YECO CRDS CRR
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Hottest Manufacturing Stocks Now – YECO AEZS XBIT GLF
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
7 Pharmaceutical Stocks to Buy Now
Seven pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
7 Pharmaceutical Stocks to Buy Now
The grades of seven pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong…
8 Pharmaceutical Stocks to Buy Now
This week, eight pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
3 – 10 of 240 results
